Exhibit 99.2


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


     In connection with the Quarterly Report of PVAXX Corporation (the
"Company") on Form 10-QSB for the period ending September 30, 2002 as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
we, Henry Stevens and Jim Halliday, Chief Executive Officer and Chief Financial
Officer, respectively, of the Company, certify, pursuant to 18 U.S.C. ss. 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

     (1)  The officers signing below have reviewed the report;

     (2)  The Report fully complies with the requirements of section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (3)  The information contained in the Report fairly presents, in all
          material respects, the financial condition and result of operations
          of the Company.

     (4) The signing officers:

          a. are responsible for establishing and maintaining internal controls;
          b. have designed such internal controls to ensure that material
             information relating to the issuer and its consolidated
             subsidiaries is made known to such officers by others within those
             entities, particularly during the period in which the periodic
             reports are being prepared;
          c. have evaluated the effectiveness of the issuer's internal controls
             as of a date within 90 days prior to the report; and
          d. have presented in the report their conclusions about the
             effectiveness of their internal controls based on their evaluation
             as of that date;

     (5) The signing officers have disclosed to the issuer's auditors and the
         audit committee of the board of directors (or persons fulfilling the
         equivalent function)-

          a. all significant deficiencies in the design or operation of internal
             controls which could adversely affect the issuer's ability to
             record, process, summarize and report financial data and have
             identified for the issuer's auditors any material weaknesses in
             internal controls; and
          b. any fraud, whether or not material, that involves management or
             other employees who have a significant role in the issuer's
             internal controls; and

     (6) The signing officers have indicated in the report whether or not there
         were significant changes in internal controls or in other factors that
         could significantly affect internal controls or in other factors that
         could significantly affect internal controls subsequent to the date of
         their evaluation, including any corrective actions with regard to
         significant deficiencies and material weaknesses.


November 14, 2002                          By: /s/ Henry Stevens
                                           -----------------------
                                           HENRY STEVENS,
                                           Chief Executive Officer


                                           By: /s/ Jim Halliday
                                           -----------------------
                                           JIM HALLIDAY,
                                           Chief Financial Officer